全文获取类型
收费全文 | 197篇 |
免费 | 13篇 |
国内免费 | 44篇 |
专业分类
儿科学 | 9篇 |
妇产科学 | 1篇 |
基础医学 | 30篇 |
口腔科学 | 9篇 |
临床医学 | 53篇 |
内科学 | 56篇 |
皮肤病学 | 5篇 |
神经病学 | 5篇 |
特种医学 | 26篇 |
外科学 | 13篇 |
综合类 | 14篇 |
预防医学 | 3篇 |
药学 | 23篇 |
肿瘤学 | 7篇 |
出版年
2022年 | 2篇 |
2021年 | 1篇 |
2020年 | 4篇 |
2019年 | 4篇 |
2017年 | 2篇 |
2016年 | 5篇 |
2015年 | 4篇 |
2014年 | 5篇 |
2013年 | 6篇 |
2012年 | 5篇 |
2011年 | 10篇 |
2010年 | 10篇 |
2009年 | 12篇 |
2008年 | 3篇 |
2007年 | 38篇 |
2006年 | 5篇 |
2005年 | 11篇 |
2004年 | 6篇 |
2003年 | 4篇 |
2001年 | 4篇 |
1999年 | 4篇 |
1998年 | 10篇 |
1997年 | 14篇 |
1996年 | 14篇 |
1995年 | 6篇 |
1994年 | 8篇 |
1993年 | 6篇 |
1992年 | 1篇 |
1991年 | 2篇 |
1990年 | 4篇 |
1989年 | 7篇 |
1988年 | 3篇 |
1987年 | 4篇 |
1986年 | 4篇 |
1985年 | 5篇 |
1984年 | 3篇 |
1983年 | 2篇 |
1982年 | 1篇 |
1981年 | 3篇 |
1980年 | 3篇 |
1978年 | 5篇 |
1975年 | 2篇 |
1971年 | 1篇 |
1934年 | 1篇 |
排序方式: 共有254条查询结果,搜索用时 171 毫秒
101.
102.
BACKGROUND & AIMS: Peripheral regulation of acid secretion depends mainly on stimulation or inhibition of the three major gastric endocrine cells (enterochromaffin-like, gastrin, and somatostatin). The aim of this paper was to define physiological responses of enterochromaffin-like, gastrin, and somatostatin cells in a mixed endocrine cell population by measuring ligand-selective changes of intracellular calcium ([Ca2+]i) in individual cells. METHODS: Endocrine cells were enriched from a rat gastric cell suspension by elutriation, a density-gradient fractionation, and a 48-hour short-term culture. [Ca2+]i responses of individual cells to various ligands such as gastrin/carboxy-terminal cholecystokinin octapeptide and selective cholecystokinin antagonists, carbachol, and gastrin-releasing peptide were monitored using video imaging in a perfusion chamber. Characteristic [Ca2+]i changes distinguished the three cell types, confirmed by immunostaining. RESULTS: All enterochromaffin-like cells respond to cholecystokinin-B receptor stimulation, but only a few respond to carbachol. Gastrin cells respond to both gastrin-releasing peptide and carbachol but not to cholecystokinin-receptor agonists. Somatostatin cells have both stimulatory cholecystokinin-A and cholecystokinin-B receptors and inhibitory muscarinic receptors. All cells have inhibitory somatostatin receptors. CONCLUSIONS: Calcium- signaling responses of gastric endocrine cells are distinctive. This allows individual cell types in a mixed population to be characterized and permits an analysis of the hormones and transmitters that act directly on a specific cell type. (Gastroenterology 1996 Jun;110(6):1835-46) 相似文献
103.
Inhibition of receptor binding and neutralization of bioactivity by anti-erythropoietin monoclonal antibodies 总被引:3,自引:0,他引:3
We have generated four high affinity monoclonal antibodies (MoAbs) to recombinant human erythropoietin (EPO). All four MoAbs immunoprecipitate radioiodinated native EPO, and the concentrations of MoAbs required for maximum binding range from 10 nmol/L to 100 nmol/L. Two MoAbs, designated Group I MoAbs, bind to an epitope within the N- terminal 20 amino acids of EPO and also immunoprecipitate sodium dodecyl sulfate (SDS)-denatured EPO. Two other MoAbs (Group II MoAbs) do not immunoprecipitate SDS-denatured EPO and do not bind to any of the eight endo C fragments of EPO. We first used murine erythroleukemia (MEL) cells to test the MoAbs for inhibition of EPO-receptor binding. MEL cells, although unresponsive to EPO, express 760 high affinity receptors for EPO per cell (Kd = 0.24 nmol/L). To assay our MoAbs, MEL cells were grown as monolayers on fibronectin-coated Petri dishes and incubated at 4 degrees C with radioiodinated EPO. Group I MoAbs do not inhibit binding of radioiodinated EPO to the MEL EPO-receptor, but Group II MoAbs do inhibit binding in a dose-dependent manner. We next examined the neutralization of EPO bioactivity by our MoAbs, using EPO- dependent cell line. Only Group II MoAbs inhibit a newly developed EPO- dependent cell growth, demonstrating that inhibition of EPO-receptor binding correlates with neutralization of EPO bioactivity. 相似文献
104.
Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake
下载免费PDF全文
![点击此处可从《HIV medicine》网站下载免费的PDF全文](/ch/ext_images/free.gif)
105.
106.
Ruchika K. Jain Amit R. Nayak Aliabbas A. Husain Milind S. Panchbhai Nitin Chandak Hemant J. Purohit Girdhar M. Taori Hatim F. Daginawala Rajpal S. Kashyap 《Disease markers》2013,35(5):311-316
The present study was designed to investigate Rv2623 antigen, a major dormancy regulon protein of Mycobacterium tuberculosis (MTB) in CSF of suspected latent and active tuberculous meningitis (TBM) patients. A total of 100 CSF samples from TBM (n = 31), suspected latent TBM (n = 22), and suitable noninfectious control subjects (n = 47) were collected and evaluated for Rv2623 antigen level using ELISA protocol. A significantly high (P < 0.05) mean absorbance was observed in samples of suspected latent TBM and active TBM patients as compared to non-TBM control patients. However, no significant difference in Rv2623 level was observed between suspected latent TBM and TBM patients. Our preliminary findings suggest that Rv2623 may be useful as a potential biomarker for the diagnosis of the latent as well as active TBM infection. Futher evaluation of this biomarker in large number of samples is therefore needed to confirm the result. 相似文献
107.
CM Schröder† HF Merk† J Frank‡ 《Journal of the European Academy of Dermatology and Venereology》2006,20(2):209-211
Hairdressers are prone to developing occupational skin diseases, particularly hand eczema of different origins. Rather uncommon, however, is the so-called barber's hair sinus that is caused by hair fragments penetrating the skin preferably in the interdigital spaces of their hands. Whereas, to date, the disease has almost exclusively been reported to occur on the hands of male hairdressers, we herein present the first case of a female hairdresser who developed a barber's hair sinus on one of her feet. 相似文献
108.
109.
AO Watts MMH van Lipzig WC Jaeger RM Seeber M van Zwam J Vinet MMC van der Lee M Siderius GJR Zaman HWGM Boddeke MJ Smit KDG Pfleger R Leurs HF Vischer 《British journal of pharmacology》2013,168(7):1662-1674
Background and Purpose
The C-X-C chemokine receptors 3 (CXCR3) and C-X-C chemokine receptors 4 (CXCR4) are involved in various autoimmune diseases and cancers. Small antagonists have previously been shown to cross-inhibit chemokine binding to CXCR4, CC chemokine receptors 2 (CCR2) and 5 (CCR5) heteromers. We investigated whether CXCR3 and CXCR4 can form heteromeric complexes and the binding characteristics of chemokines and small ligand compounds to these chemokine receptor heteromers.Experimental Approach
CXCR3–CXCR4 heteromers were identified in HEK293T cells using co-immunoprecipitation, time-resolved fluorescence resonance energy transfer, saturation BRET and the GPCR-heteromer identification technology (HIT) approach. Equilibrium competition binding and dissociation experiments were performed to detect negative binding cooperativity.Key Results
We provide evidence that chemokine receptors CXCR3 and CXCR4 form heteromeric complexes in HEK293T cells. Chemokine binding was mutually exclusive on membranes co-expressing CXCR3 and CXCR4 as revealed by equilibrium competition binding and dissociation experiments. The small CXCR3 agonist VUF10661 impaired binding of CXCL12 to CXCR4, whereas small antagonists were unable to cross-inhibit chemokine binding to the other chemokine receptor. In contrast, negative binding cooperativity between CXCR3 and CXCR4 chemokines was not observed in intact cells. However, using the GPCR-HIT approach, we have evidence for specific β-arrestin2 recruitment to CXCR3-CXCR4 heteromers in response to agonist stimulation.Conclusions and Implications
This study indicates that heteromeric CXCR3–CXCR4 complexes may act as functional units in living cells, which potentially open up novel therapeutic opportunities. 相似文献110.
Peter A. McCullough MD MPH Denise Barnard MD Robert Clare MS Stephen J. Ellis PhD Jerome L. Fleg MD Gregg C. Fonarow MD Barry A. Franklin PhD Ryan D. Kilpatrick PhD Dalane W. Kitzman MD Christopher M. O'Connor MD Ileana L. Piña MD MPH Udho Thadani MD Vinay Thohan MD David J. Whellan MD MHS for the HF‐ACTION Investigators 《Clinical cardiology》2013,36(10):611-620